Delivery Order 36C25523D0025-36C25524N0276
- Not listed
- This is a delivery order awarded by the Veterans Integrated Service Network 15 (VISN 15) of the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The contract provides $111,821.84 in firm fixed-price funding for whole blood glucose testing supplies over a 5-year ordering period ending on May 31, 2026. This delivery order was placed against a larger Indefinite Delivery Indefinite...
- This is a federal contract award from the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and medical products. The contract is for the provision of whole blood glucose testing supplies to the VA's VISN 15 medical centers, with an ordering period extension for the St. Louis VA Medical Center. The contract has a ceiling value of $223,029.35 and is a firm fixed-price delivery order. It does not have a set-aside designation,...
- This is a delivery order awarded by the Veterans Integrated Service Network 22 (VISN 22) of the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $59,891.02 firm-fixed-price contract is for the delivery of glucose meters and consumables, with a performance period ending on January 7, 2026. The contract is not set aside and is part of Roche's existing portfolio of...
- The Department of Veterans Affairs, Veterans Integrated Service Network 20 (VISN 20) awarded a delivery order to Roche Diagnostics Corporation for reagents, consumables, and supplies supporting whole blood glucose testing operations. This $23.7K firm fixed-price delivery order, effective November 1, 2025, through September 30, 2026, represents a child contract under a larger procurement vehicle and was awarded without set-aside designation. The contract supplies critical point-of-care testing...
- This federal contract award is for a delivery order to provide glucometer supplies to the Veterans Integrated Service Network 22 (VISN 22), which is part of the U.S. Department of Veterans Affairs (VA). The prime contractor is Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The delivery order has a ceiling value of $39,539.92 and is a...
- The U.S. Department of Veterans Affairs (Veterans Integrated Service Network 22) awarded a delivery order to Roche Diagnostics Corporation for $50,512.39 under a firm fixed-price contract. This delivery order, which carries no set-aside designation, represents an addition of a no-cost line item to an existing contract vehicle. The award is effective as of January 8, 2026, with a completion date of January 7, 2027, and the work will be performed in Tucson, Arizona. As a delivery order, this...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23, awarded a delivery order valued at $91,139.86 to Roche Diagnostics Corporation for testing supplies. This contract, issued on October 15, 2025, with an ultimate completion date of October 14, 2026, operates under a firm fixed price structure with no set-aside designation. Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and laboratory instruments, serves as the prime contractor and will...
- This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 20 (VISN 20) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The $1,665.60 contract provides reagents, consumables, and supplies for whole blood glucose testing to support healthcare delivery within the VA system. The award is not designated as a set-aside. Roche Diagnostics holds multiple significant Indefinite Delivery Contracts...
- The Department of Veterans Affairs, Veterans Integrated Service Network 22, awarded a delivery order to Roche Diagnostics Corporation for a Chemistry Immunoassay System on November 26, 2025. This firm fixed-price contract, valued at $1,351,275.80 with an ultimate completion date of November 25, 2026, will be performed at the VA Medical Center in Loma Linda, California. The award represents a child contract under a larger indefinite delivery vehicle and carries no set-aside designation,...
- This is a delivery order contract awarded by the Veterans Integrated Service Network 20 (VISN 20) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostic products and services. The $1,199 firm-fixed-price contract is for the supply of reagents, consumables, and supplies for whole blood glucose testing to support the Department of Veterans Affairs (VA) healthcare system. The contract has an ultimate completion date of September 30, 2026 and is not...
- 36C25523D0025Indefinite Delivery Contract
- 36C25523D0025-36C25524N0276Delivery Order
The Department of Veterans Affairs (VA), Veterans Integrated Service Network 15, awarded a $177.3K delivery order to Roche Diagnostics Corporation for glucose monitoring systems at the Columbia VA Medical Center. Issued on June 1, 2024, this firm fixed-price contract represents Order Period II and is structured as a closeout action for a previous purchase order (589C43155). The delivery order operates under a larger contract vehicle, likely a GSA Schedule or Indefinite Delivery Contract, and carries an ultimate completion date of May 31, 2025. No set-aside designation was used in this competitive award. The place of performance is St. Louis, Missouri. Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostic equipment and reagents, is the prime contractor on this delivery order. The company is a global leader in diagnostic solutions with extensive federal healthcare experience, holding multiple significant contracts across the VA, Defense Health Agency, and other federal agencies. This award reflects Roche's established role in supplying point-of-care testing devices and diagnostic technologies to support VA medical operations. The contract directly supports clinical patient care at the Columbia VAMC through the provision of glucose monitoring systems, a critical component of diabetes management and general medical diagnostics in the VA healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($4k) | 12/16/25 | |
| P00001 | Funding Only Action | ($7k) | 10/7/25 | |
| Not listed | Not listed | $188.2k | 5/21/24 |